Uptake of Tropheryma whipplei by Intestinal Epithelia

Int J Mol Sci. 2023 Mar 24;24(7):6197. doi: 10.3390/ijms24076197.

Abstract

Background: Tropheryma whipplei (TW) can cause different pathologies, e.g., Whipple's disease and transient gastroenteritis. The mechanism by which the bacteria pass the intestinal epithelial barrier, and the mechanism of TW-induced gastroenteritis are currently unknown.

Methods: Using ex vivo disease models comprising human duodenal mucosa exposed to TW in Ussing chambers, various intestinal epithelial cell (IEC) cultures exposed to TW and a macrophage/IEC coculture model served to characterize endocytic uptake mechanisms and barrier function.

Results: TW exposed ex vivo to human small intestinal mucosae is capable of autonomously entering IECs, thereby invading the mucosa. Using dominant-negative mutants, TW uptake was shown to be dynamin- and caveolin-dependent but independent of clathrin-mediated endocytosis. Complementary inhibitor experiments suggested a role for the activation of the Ras/Rac1 pathway and actin polymerization. TW-invaded IECs underwent apoptosis, thereby causing an epithelial barrier defect, and were subsequently subject to phagocytosis by macrophages.

Conclusions: TW enters epithelia via an actin-, dynamin-, caveolin-, and Ras-Rac1-dependent endocytosis mechanism and consecutively causes IEC apoptosis primarily in IECs invaded by multiple TW bacteria. This results in a barrier leak. Moreover, we propose that TW-packed IECs can be subject to phagocytic uptake by macrophages, thereby opening a potential entry point of TW into intestinal macrophages.

Keywords: Tropheryma whipplei; Ussing chamber; Whipple’s disease; apoptosis; barrier function; caveolin; endocytosis; gastroenteritis; invasion.

MeSH terms

  • Actins / metabolism
  • Gastroenteritis* / microbiology
  • Humans
  • Intestinal Mucosa / metabolism
  • Macrophages / microbiology
  • Tropheryma* / physiology

Substances

  • Actins